Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
Free White Paper
As a guest to ChinaBio® Today, you have access to summaries of over 3000 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
BioSense Inks $68 Million Deal for Neovacs’ Autoimmune Disease Vaccine in China | February 21, 2017
WuXi Biologics Files for $300 Million (?) Hong Kong IPO | January 25, 2017
Sanpower and CITIC to Raise $2.9 Billion for Sanpower's Healthcare M&A | January 23, 2017
China's Sanpower Acquires Dendreon for $820 Million | January 10, 2017
Fosun Forms $95 Million China CAR-T JV with Kite Pharma | January 10, 2017>> See all top stories...
ChinaBio® in the News